Search in:

Expert Opinion on Pharmacotherapy Volume 10, 2009 - Issue 16

Submit an article Journal homepage

272

Views

CrossRef citations to date

Altmetric

Reviews

Alpha-1 antitrypsin (AAT) deficiency - what are the treatment options?

Ariel Modrykamien Fellow, Cleveland Clinic, Respiratory Institute, Cleveland, Ohio, USA

, MD &

James K Stoller Jean Wall Bennett Professor of Medicine, Executive Director, Physician Leadership Development and Head, Chairman, Cleveland Clinic Lerner College of Medicine, Education Institute, Respiratory Institute, Cleveland Clinic, Respiratory Therapy, A90, 9500 Euclid Avenue, Cleveland, OH 44195, USA +1 216 444 1960; +1 216 445 8160; [email protected]

, MD MS

Pages 2653-2661 | Published online: 15 Oct 2009

Cite this article
https://doi.org/10.1517/14656560903300111

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Bibliography

Wood AM, Stockley RA. Alpha one antitrypsin deficiency: from gene to treatment. Respiration 2007;74:481-92
PubMed Web of Science ®Google Scholar
Ranes J, Stoller JK. A review of alpha-1 antitrypsin deficiency. Semin Respir Crit Care Med 2005;26:154-66
PubMed Web of Science ®Google Scholar
Laurell CB, Eriksson S. [Hypo-Alpha-1 Antitrypsinemia.]. Verh Dtsch Ges Inn Med 1964;70:537-9
PubMedGoogle Scholar
Laurell CB, Eriksson S. The serum alpha-1 antitrypsin in families with hypo-Alpha-L-antitrypsinemia. Clin Chim Acta 1965;11:395-8
PubMed Web of Science ®Google Scholar
Carrell RW. What we owe to alpha-(1)antitrypsin and to Carl-Bertil Laurell. COPD 2004;1:71-84
PubMedGoogle Scholar
Sveger T. Liver disease in alpha-1 antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976;294:1316-21
PubMed Web of Science ®Google Scholar
O'Brien ML, Buist NR, Murphey WH. Neonatal screening for alpha-1 antitrypsin deficiency. J Pediatr 1978;92:1006-10
PubMed Web of Science ®Google Scholar
Silverman EK, Miletich JP, Pierce JA, Alpha-1 antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening. Am Rev Respir Dis 1989;140:961-6
PubMed Web of Science ®Google Scholar
Spence WC, Morris JE, Pass K, Murphy PD. Molecular confirmation of alpha-1 antitrypsin genotypes in newborn dried blood specimens. Biochem Med Metab Biol 1993;50:233-40
PubMedGoogle Scholar
DeMeo DL, Silverman EK. Alpha-1 antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax 2004;59:259-64
PubMed Web of Science ®Google Scholar
Brantly M, Nukiwa T, Crystal RG. Molecular basis of alpha-1 antitrypsin deficiency. Am J Med 1988;84:13-31
PubMed Web of Science ®Google Scholar
Stoller JK, Aboussouan LS. Alpha-1 antitrypsin deficiency. Lancet 2005;365:2225-36
PubMed Web of Science ®Google Scholar
Fishman A, Martinez F, Naunheim K, A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-73
PubMed Web of Science ®Google Scholar
Tutic M, Bloch KE, Lardinois D, Long-term results after lung volume reduction surgery in patients with alpha-1 antitrypsin deficiency. J Thorac Cardiovasc Surg 2004;128:408-13
PubMed Web of Science ®Google Scholar
Stoller JK, Gildea TR, Ries AL, Lung volume reduction surgery in patients with emphysema and alpha-1 antitrypsin deficiency. Ann Thorac Surg 2007;83:241-51
PubMed Web of Science ®Google Scholar
Stoller JK. Clinical features and natural history of severe alpha-1 antitrypsin deficiency. Roger S. Mitchell Lecture. Chest 1997;111:123S-8S
PubMed Web of Science ®Google Scholar
Hubbard RC, Crystal RG. Alpha-1-antitrypsin augmentation therapy for alpha-1 antitrypsin deficiency. Am J Med 1988;84:52-62
PubMed Web of Science ®Google Scholar
Gadek JE, Klein HG, Holland PV, Crystal RG. Replacement therapy of alpha-1 antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects. J Clin Invest 1981;68:1158-65
PubMed Web of Science ®Google Scholar
Wewers MD, Casolaro MA, Sellers SE, Replacement therapy for alpha-1 antitrypsin deficiency associated with emphysema. N Engl J Med 1987;316:1055-62
PubMed Web of Science ®Google Scholar
Kolarich D, Turecek PL, Weber A, Biochemical, molecular characterization, and glycoproteomic analyses of alpha-(1) proteinase inhibitor products used for replacement therapy. Transfusion 2006;46:1959-77
PubMed Web of Science ®Google Scholar
Hubbard RC, Sellers S, Czerski D, Biochemical efficacy and safety of monthly augmentation therapy for alpha-1 antitrypsin deficiency. Jama 1988;260:1259-64
PubMed Web of Science ®Google Scholar
Barker AF, Iwata-Morgan I, Oveson L, Roussel R. Pharmacokinetic study of alpha-1 antitrypsin infusion in alpha1-antitrypsin deficiency. Chest 1997;112:607-13
PubMed Web of Science ®Google Scholar
Piitulainen E, Bernspang E, Bjorkman S, Berntorp E. Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha-(1) antitrypsin. Eur J Clin Pharmacol 2003;59:151-6
PubMed Web of Science ®Google Scholar
Stoller JK, Rouhani F, Brantly M, Biochemical efficacy and safety of a new pooled human plasma alpha-(1) antitrypsin, Respitin. Chest 2002;122:66-74
PubMed Web of Science ®Google Scholar
Heresi GA, Stoller JK. Augmentation therapy in alpha-1 antitrypsin deficiency. Expert Opin Biol Ther 2008;8:515-26
PubMed Web of Science ®Google Scholar
Stocks JM, Brantly M, Pollock D, Multi-center study: the biochemical efficacy, safety and tolerability of a new alpha-1 proteinase inhibitor, Zemaira. Copd 2006;3:17-23
PubMedGoogle Scholar
Seersholm N, Wencker M, Banik N, Does alpha-1 antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha-1 AT study group. Eur Respir J 1997;10:2260-3
PubMed Web of Science ®Google Scholar
The Alpha-1-Antitrypsin Deficiency Registry Study Group. Survival and FEV1 decline in individuals with severe deficiency of alpha-1 antitrypsin. Am J Respir Crit Care Med 1998;158:49-59
Google Scholar
Dirksen A, Dijkman JH, Madsen F, A randomized clinical trial of alpha-(1) antitrypsin augmentation therapy. Am J Respir Crit Care Med 1999;160:1468-72
PubMed Web of Science ®Google Scholar
Dirksen A, Piitulainen E, Parr DG, Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha-1 antitrypsin deficiency. Eur Respir J 2009;33:1345-53
PubMed Web of Science ®Google Scholar
Gottlieb DJ, Luisetti M, Stone PJ, Short-term supplementation therapy does not affect elastin degradation in severe alpha-(1) antitrypsin deficiency. The American-Italian AATD Study Group. Am J Respir Crit Care Med 2000;162:2069-72
PubMed Web of Science ®Google Scholar
Lieberman J. Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data. Chest 2000;118:1480-5
PubMed Web of Science ®Google Scholar
Wencker M, Fuhrmann B, Banik N, Konietzko N. Longitudinal follow-up of patients with alpha-(1) protease inhibitor deficiency before and during therapy with IV alpha-(1) protease inhibitor. Chest 2001;119:737-44
PubMed Web of Science ®Google Scholar
Stockley RA, Bayley DL, Unsal I, Dowson LJ. The effect of augmentation therapy on bronchial inflammation in alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2002;165:1494-8
PubMed Web of Science ®Google Scholar
American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003;168:818-900
PubMed Web of Science ®Google Scholar
Dawkins PA, Dawkins CL, Wood AM, Rate of progression of lung function impairment in alpha-1 antitrypsin deficiency. Eur Respir J 2009;33:1338-44
PubMed Web of Science ®Google Scholar
Piliang MP, Stoller JK. Women with ulcerating, painful skin lesions. Cleve Clin J Med 2008;75:414, 418, 422
Google Scholar
Wencker M, Banik N, Buhl R, [Long-term therapy of alpha-1 antitrypsin-deficiency-associated pulmonary emphysema with human alpha-1 antitrypsin]. Pneumologie 1998;52:545-52
PubMedGoogle Scholar
Stoller JK, Fallat R, Schluchter MD, Augmentation therapy with alpha-1 antitrypsin: patterns of use and adverse events. Chest 2003;123:1425-34
PubMed Web of Science ®Google Scholar
Flotte TR, Brantly ML, Spencer LT, Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha-1 antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults. Hum Gene Ther 2004;15:93-128
PubMed Web of Science ®Google Scholar
Song S, Morgan M, Ellis T, Sustained secretion of human alpha-1 antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc Natl Acad Sci USA 1998;95:14384-8
PubMed Web of Science ®Google Scholar
Brantly ML, Spencer LT, Humphries M, Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alpha-l antitrypsin (AAT) vector in AAT-deficient adults. Hum Gene Ther 2006;17:1177-86
PubMed Web of Science ®Google Scholar
Parfrey H, Dafforn TR, Belorgey D, Inhibiting polymerization: new therapeutic strategies for Z alpha-1 antitrypsin-related emphysema. Am J Respir Cell Mol Biol 2004;31:133-9
PubMed Web of Science ®Google Scholar
Cruz PE, Mueller C, Cossette TL, In vivo post-transcriptional gene silencing of alpha-1 antitrypsin by adeno-associated virus vectors expressing siRNA. Lab Invest 2007;87:893-902
PubMed Web of Science ®Google Scholar
Burrows JA, Willis LK, Perlmutter DH. Chemical chaperones mediate increased secretion of mutant alpha-1 antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc Natl Acad Sci USA 2000;97:1796-801
PubMed Web of Science ®Google Scholar
Cantin AM, Woods DE, Cloutier D, Polyethylene glycol conjugation at Cys232 prolongs the half-life of alpha-1 proteinase inhibitor. Am J Respir Cell Mol Biol 2002;27:659-65
PubMed Web of Science ®Google Scholar
McNab GL, Ahmad A, Mistry D, Stockley RA. Modification of gene expression and increase in alpha-1 antitrypsin (alpha1 AT) secretion after homologous recombination in alpha1-AT-deficient monocytes. Hum Gene Ther 2007;18:1171-7
PubMed Web of Science ®Google Scholar
Hubbard RC, Casolaro MA, Mitchell M, Fate of aerosolized recombinant DNA-produced alpha-1 antitrypsin: use of the epithelial surface of the lower respiratory tract to administer proteins of therapeutic importance. Proc Natl Acad Sci USA 1989;86:680-4
PubMed Web of Science ®Google Scholar
Spencer LT, Humphries JE, Brantly ML. Antibody response to aerosolized transgenic human alpha-1 antitrypsin. N Engl J Med 2005;352:2030-1
PubMed Web of Science ®Google Scholar
Gildea TR, Shermock KM, Singer ME, Stoller JK. Cost-effectiveness analysis of augmentation therapy for severe alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003;167:1387-92
PubMed Web of Science ®Google Scholar
Sandhaus RA, Turino G, Stocks J, Alpha-1 antitrypsin augmentation therapy for PI*MZ heterozygotes: a cautionary note. Chest 2008;134:831-4
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Alpha-1 antitrypsin (AAT) deficiency - what are the treatment options?

Bibliography

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Alpha-1 antitrypsin (AAT) deficiency - what are the treatment options?

Bibliography

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date